Literature DB >> 26787702

Novel Genes Related to Ceftriaxone Resistance Found among Ceftriaxone-Resistant Neisseria gonorrhoeae Strains Selected In Vitro.

Zijian Gong1, Wei Lai2, Min Liu3, Zhengshuang Hua4, Yayin Sun5, Qingfang Xu1, Yue Xia1, Yue Zhao1, Xiaoyuan Xie1.   

Abstract

The emergence of ceftriaxone-resistantNeisseria gonorrhoeaeis currently a global public health concern. However, the mechanism of ceftriaxone resistance is not yet fully understood. To investigate the potential genes related to ceftriaxone resistance inNeisseria gonorrhoeae, we subcultured six gonococcal strains with increasing concentrations of ceftriaxone and isolated the strains that became resistant. After analyzing several frequently reported genes involved in ceftriaxone resistance, we found only a single mutation inpenA(A501V). However, differential analysis of the genomes and transcriptomes between pre- and postselection strains revealed many other mutated genes as well as up- and downregulated genes. Transformation of the mutatedpenAgene into nonresistant strains increased the MIC between 2.0- and 5.3-fold, and transformation of mutatedftsXincreased the MIC between 3.3- and 13.3-fold. Genes encoding the ABC transporters FarB, Tfq, Hfq, and ExbB were overexpressed, whilepilM,pilN, andpilQwere downregulated. Furthermore, the resistant strain developed cross-resistance to penicillin and cefuroxime, had an increased biochemical metabolic rate, and presented fitness defects such as prolonged growth time and downregulated PilMNQ. In conclusion, antimicrobial pressure could result in the emergence of ceftriaxone resistance, and the evolution of resistance ofNeisseria gonorrhoeaeto ceftriaxone is a complicated process at both the pretranscriptional and posttranscriptional levels, involving several resistance mechanisms of increased efflux and decreased entry.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26787702      PMCID: PMC4808169          DOI: 10.1128/AAC.00149-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  49 in total

1.  Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae.

Authors:  Sho Takahata; Nami Senju; Yumi Osaki; Takuji Yoshida; Takashi Ida
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

2.  A proteomic analysis of penicillin resistance in Streptococcus pneumoniae reveals a novel role for PstS, a subunit of the phosphate ABC transporter.

Authors:  Hafid Soualhine; Vicky Brochu; François Ménard; Barbara Papadopoulou; Karl Weiss; Michel G Bergeron; Danielle Légaré; Jolyne Drummelsmith; Marc Ouellette
Journal:  Mol Microbiol       Date:  2005-12       Impact factor: 3.501

3.  Annual report of the Australian Gonococcal Surveillance Programme, 2000.

Authors: 
Journal:  Commun Dis Intell Q Rep       Date:  2001-04

Review 4.  Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies.

Authors:  Kimberly A Workowski; Stuart M Berman; John M Douglas
Journal:  Ann Intern Med       Date:  2008-04-15       Impact factor: 25.391

5.  European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe.

Authors:  I M C Martin; S Hoffmann; C A Ison
Journal:  J Antimicrob Chemother       Date:  2006-07-01       Impact factor: 5.790

6.  The enterococcal ABC transporter gene lsa(E) confers combined resistance to lincosamides, pleuromutilins and streptogramin A antibiotics in methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Authors:  Sarah Wendlandt; Carmen Lozano; Kristina Kadlec; Elena Gómez-Sanz; Myriam Zarazaga; Carmen Torres; Stefan Schwarz
Journal:  J Antimicrob Chemother       Date:  2012-10-09       Impact factor: 5.790

7.  High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.

Authors:  Magnus Unemo; Daniel Golparian; Robert Nicholas; Makoto Ohnishi; Anne Gallay; Patrice Sednaoui
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

8.  Increase in reported gonorrhoea cases in Sweden, 2001 - 2008.

Authors:  I Velicko; M Unemo
Journal:  Euro Surveill       Date:  2009-08-27

9.  The epidemiology of gonorrhoea in Norway, 1993-2007: past victories, future challenges.

Authors:  Irena Jakopanec; Katrine Borgen; Preben Aavitsland
Journal:  BMC Infect Dis       Date:  2009-03-19       Impact factor: 3.090

10.  TetAB46, a predicted heterodimeric ABC transporter conferring tetracycline resistance in Streptococcus australis isolated from the oral cavity.

Authors:  Philip J Warburton; Lena Ciric; Avigdor Lerner; Lorna A Seville; Adam P Roberts; Peter Mullany; Elaine Allan
Journal:  J Antimicrob Chemother       Date:  2012-08-30       Impact factor: 5.790

View more
  13 in total

1.  Point-by-Point Progress: Gonorrhea Point of Care Tests.

Authors:  Charlotte A Gaydos; Johan H Melendez
Journal:  Expert Rev Mol Diagn       Date:  2020-06-30       Impact factor: 5.225

2.  Ceftriaxone-Resistant Neisseria gonorrhoeae Isolates (2010 to 2014) in France Characterized by Using Whole-Genome Sequencing.

Authors:  Claire de Curraize; Sylvain Kumanski; Maïté Micaëlo; Nelly Fournet; Guy La Ruche; Fabienne Meunier; Rishma Amarsy; Hervé Jacquier; Emmanuelle Cambau; Agathe Goubard; Béatrice Bercot
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

3.  Antimicrobial Consumption and Susceptibility of Neisseria gonorrhoeae: A Global Ecological Analysis.

Authors:  Chris Kenyon; Jozefien Buyze; Teodora Wi
Journal:  Front Med (Lausanne)       Date:  2018-11-27

4.  Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016-2019.

Authors:  Xiaomian Lin; Wentao Chen; Qinghui Xie; Yuqi Yu; Yiwen Liao; Zhanjin Feng; Xiaolin Qin; Xingzhong Wu; Sanmei Tang; Heping Zheng
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

Review 5.  Resistance to β-Lactams in Neisseria ssp Due to Chromosomally Encoded Penicillin-Binding Proteins.

Authors:  André Zapun; Cécile Morlot; Muhamed-Kheir Taha
Journal:  Antibiotics (Basel)       Date:  2016-09-28

6.  Evolution of Antibiotic Resistance without Antibiotic Exposure.

Authors:  Anna Knöppel; Joakim Näsvall; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

7.  Producing polished prokaryotic pangenomes with the Panaroo pipeline.

Authors:  Gerry Tonkin-Hill; Neil MacAlasdair; Christopher Ruis; Aaron Weimann; Gal Horesh; John A Lees; Rebecca A Gladstone; Stephanie Lo; Christopher Beaudoin; R Andres Floto; Simon D W Frost; Jukka Corander; Stephen D Bentley; Julian Parkhill
Journal:  Genome Biol       Date:  2020-07-22       Impact factor: 13.583

8.  Antibiotic Susceptibility Monitoring of Neisseria gonorrhoeae in Bacolod City, Philippines.

Authors:  Clark Martin P Araneta; Alain C Juayang; Joseph Peter T Lim; Eleeza Marie G Quilop; Nadine Joy G Casaysay; Gene Marie L Tamesis; Tricia Marie G Yude; Sarah Joyce E Romero; Raziel C Gayoba
Journal:  Trop Med Infect Dis       Date:  2017-08-29

9.  Genomic epidemiology and population structure of Neisseria gonorrhoeae from remote highly endemic Western Australian populations.

Authors:  Barakat A Al Suwayyid; Geoffrey W Coombs; David J Speers; Julie Pearson; Michael J Wise; Charlene M Kahler
Journal:  BMC Genomics       Date:  2018-02-27       Impact factor: 3.969

10.  Comparative Proteomics of Extended-Spectrum Cephalosporin-Resistant Neisseria gonorrhoeae Isolates Demonstrates Altered Protein Synthesis, Metabolism, Substance Transport, and Membrane Permeability.

Authors:  Nannan Diao; Guoquan Yan; Yang Yang; Yuan Dong; Ying Wang; Weiming Gu
Journal:  Front Microbiol       Date:  2020-02-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.